Sedia Biosciences Corp - Product Pipeline Analysis, 2018 Update

  • ID: 4432356
  • Company Profile
  • 26 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • AxCell Biosciences Corp
  • LEAP Biosciences Corp
  • Sekisui Diagnostics LLC
  • MORE
Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen collection devices. It offers diagnostic products, epidemiological products, clinical products, rapid point of care diagnostic assays, novel epidemiological disease surveillance assays, monitoring devices and other public health tools. SBC provides services such as technology licensing, commercialization, medical device manufacturing and distributing, diagnostic testing, monitoring, white labeling, and technology transfer and development services. The company markets its products in the US and other European and Asian countries. SBC is headquartered in Portland, Oregon, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Sedia Biosciences Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AxCell Biosciences Corp
  • LEAP Biosciences Corp
  • Sekisui Diagnostics LLC
  • MORE
  • Sedia Biosciences Corp Company Overview
  • Sedia Biosciences Corp Company Snapshot
  • Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Sedia Biosciences Corp - Pipeline Analysis Overview
  • Sedia Biosciences Corp - Key Facts
  • Sedia Biosciences Corp - Major Products and Services
  • Sedia Biosciences Corp Pipeline Products by Development Stage
  • Sedia Biosciences Corp Pipeline Products Overview
  • Asanté Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test
  • Asanté Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test Product Overview
  • Asanté Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test
  • Asanté Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test Product Overview
  • Asanté Rapid HIV-1 Recency (or Incidence) Assay
  • Asanté Rapid HIV-1 Recency (or Incidence) Assay Product Overview
  • Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test
  • Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test Product Overview
  • Rapid Oral Fluid HIV Test
  • Rapid Oral Fluid HIV Test Product Overview
  • Rapid Syphilis Oral Fluid Test
  • Rapid Syphilis Oral Fluid Test Product Overview
  • Sedia Biosciences Corp - Key Competitors
  • Sedia Biosciences Corp - Key Employees
  • Sedia Biosciences Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Sedia Biosciences Corp, Recent Developments
  • Aug 30, 2016: Sedia Biosciences Awarded Additional $1.8 M NIH Grant for Novel Rapid HIV Test for Recent Infections
  • Sep 21, 2015: Sedia Biosciences Expands Its HIV-1 LAg-Avidity Assay for Recent HIV-1 Infections to Dried Blood Spot Specimens
  • Oct 23, 2014: Independent Study Shows Sedia’s New HIV-1 LAg-Avidity Test is Top Performing Incidence Assay
  • Aug 18, 2014: NIH Awards Sedia Biosciences $195,490 SBIR Grant for Rapid HIV-1 Incidence Assay
  • Aug 13, 2014: Sedia Biosciences Launches Asanté DNA, A New DNA Specimen Collection Kit
  • Feb 12, 2014: Sedia Biosciences Receives $1.0 Million NIH Grant for New HIV Diagnostic Assay
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Sedia Biosciences Corp Pipeline Products by Equipment Type
  • Sedia Biosciences Corp Pipeline Products by Indication
  • Sedia Biosciences Corp, Key Facts
  • Sedia Biosciences Corp, Major Products and Services
  • Sedia Biosciences Corp Number of Pipeline Products by Development Stage
  • Sedia Biosciences Corp Pipeline Products Summary by Development Stage
  • Asanté Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test - Product Status
  • Asanté Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test - Product Description
  • Asanté Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - Product Status
  • Asanté Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - Product Description
  • Asanté Rapid HIV-1 Recency (or Incidence) Assay - Product Status
  • Asanté Rapid HIV-1 Recency (or Incidence) Assay - Product Description
  • Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test - Product Status
  • Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test - Product Description
  • Rapid Oral Fluid HIV Test - Product Status
  • Rapid Oral Fluid HIV Test - Product Description
  • Rapid Syphilis Oral Fluid Test - Product Status
  • Rapid Syphilis Oral Fluid Test - Product Description
  • Sedia Biosciences Corp, Key Employees
  • Sedia Biosciences Corp, Subsidiaries
  • Glossary
List of Figures
  • Sedia Biosciences Corp Pipeline Products by Equipment Type
  • Sedia Biosciences Corp Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Sekisui Diagnostics LLC
  • InQ Biosciences Corporation
  • Helicos BioSciences Corporation
  • ISK Biosciences Corporation
  • AxCell Biosciences Corp
  • LEAP Biosciences Corp
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll